IBT
TCDA

International Biotechnology Trust’s Tricida, Inc. Common Stock TCDA Stock Holding History

International Biotechnology Trust’s Portfolio TCDA Stock Details TCDA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-29,000
Closed -$635K – 59
2020
Q1 		$635K Sell
29,000
-8,000
-22% -$257K 0.29% 48
2019
Q4 		$1.39M Hold
37,000
– – 0.5% 42
2019
Q3 		$1.14M Buy
37,000
+17,000
+85% +$569K 0.53% 38
2019
Q2 		$788K Buy
20,000
+934
+5% +$32.8K 0.29% 56
2019
Q1 		$751K Buy
+19,066
New +$444K 0.28% 58

Other funds holding TCDA

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
Alkeon Capital Management
Alkeon Capital Management New York $59.5B AUM 51.63% 1-Year Est. Return

International Biotechnology Trust's TCDA Position: Q2 2020 in Review

International Biotechnology Trust sold out of Tricida, Inc. Common Stock (TCDA) in Q2 2020, closing a stake of 29,000 shares — an estimated $635K sold.

International Biotechnology Trust first reported a position in TCDA in Q1 2019 and held it in 5 quarters. The position peaked at $1.39M in Q4 2019. 114 funds tracked by Wall St. Rank hold TCDA as of Q2 2020.

  • International Biotechnology Trust reported no remaining Tricida, Inc. Common Stock position as of Q2 2020 after selling out during the quarter.
  • International Biotechnology Trust sold 29,000 Tricida, Inc. Common Stock shares in Q2 2020, an estimated $635K.
  • International Biotechnology Trust first reported a position in Tricida, Inc. Common Stock in Q1 2019 and held it in 5 quarters.
  • International Biotechnology Trust's Tricida, Inc. Common Stock position peaked at $1.39M in Q4 2019.
  • 114 funds tracked by Wall St. Rank held Tricida, Inc. Common Stock as of Q2 2020.

Based on International Biotechnology Trust's 13F filing for Q2 2020, filed 14 Jul 2020.